# Commission Implementing Regulation (EU) No 103/2013 of 4 February 2013 amending Regulation (EC) No 786/2007 as regards the name of the holder of the authorisation of a preparation of endo-1,4-beta-mannanase EC 3.2.1.78 (Hemicell) (Text with EEA relevance), Article 1

Extent: E+W+S+N.I.

In column 2 of the Annex to Regulation (EC) No 786/2007 the words ‘ChemGen Corp., represented by Disproquima S.L.’ are replaced by ‘Eli Lilly and Company Ltd’.

---
Source: https://www.legislation.gov.uk/eur/2013/103/article/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-103/article-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.